Abbott (NYSE: ABT) announced today the U.S. launch and the first commercial uses of the new EnSite Precision™ cardiac mapping ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE